Virological and immunological determinants of hepatitis E virus infection outcomes.
1/5 보강
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide, especially in regions with limited sanitation infrastructure.
APA
Wang X, Bian L, et al. (2025). Virological and immunological determinants of hepatitis E virus infection outcomes.. Current opinion in virology, 73, 101491. https://doi.org/10.1016/j.coviro.2025.101491
MLA
Wang X, et al.. "Virological and immunological determinants of hepatitis E virus infection outcomes.." Current opinion in virology, vol. 73, 2025, pp. 101491.
PMID
40974759
Abstract
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide, especially in regions with limited sanitation infrastructure. Unlike hepatitis B virus (HBV) and hepatitis C virus (HCV) - which frequently progress to chronic infections associated with cirrhosis and hepatocellular carcinoma - HEV typically leads to acute and self-resolving infection in immunocompetent individuals. This review explores the mechanistic underpinnings that distinguish HEV's clinical trajectory from HBV and HCV, focusing on viral genome organization, replication strategies, immune evasion tactics, and host immune responses. Understanding these factors provides critical insights into the determinants of viral clearance versus persistence and may guide future vaccine and antiviral development.
MeSH Terms
Hepatitis E; Humans; Hepatitis E virus; Immune Evasion; Virus Replication; Genome, Viral; Animals; Host-Pathogen Interactions
같은 제1저자의 인용 많은 논문 (5)
- The Pendulum Movement of Orbital Fat and Retro-Orbicularis Oculi Fat: A New Strategy for Correction of Sunken Eyelid Deformity in Revision Upper Blepharoplasty for Asian Patients.
- Lifting the midface using a hyaluronic acid filler with lidocaine: A randomized multi-center study in a Chinese population.
- Study on the Effects of Estradiol in Staphylococcus epidermidis Device-Related Capsule Formation.
- Lipid Droplet-Targeted Biomimetic Liposomes Potentiate Chemo-Ferroptosis Therapy in Leukemia.
- An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibition.